Macquarie Group’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-203,200
| Closed | -$299K | – | 2567 |
|
|
2022
Q2 | $299K | Sell |
203,200
-2,631
| -1% | -$1.93K | ﹤0.01% | 1648 |
|
|
2022
Q1 | $237 | Hold |
205,831
| – | – | ﹤0.01% | 1778 |
|
|
2021
Q4 | $515K | Hold |
205,831
| – | – | ﹤0.01% | 1650 |
|
|
2021
Q3 | $1.05M | Hold |
205,831
| – | – | ﹤0.01% | 1571 |
|
|
2021
Q2 | $1.71M | Hold |
205,831
| – | – | ﹤0.01% | 1457 |
|
|
2021
Q1 | $1.79M | Sell |
205,831
-1,049
| -0.5% | -$10.9K | ﹤0.01% | 1237 |
|
|
2020
Q4 | $2.25M | Hold |
206,880
| – | – | ﹤0.01% | 1067 |
|
|
2020
Q3 | $2.47M | Hold |
206,880
| – | – | ﹤0.01% | 986 |
|
|
2020
Q2 | $3.32M | Sell |
206,880
-711
| -0.3% | -$12.4K | 0.01% | 884 |
|
|
2020
Q1 | $3.22M | Buy |
207,591
+4,391
| +2% | +$94.3K | 0.01% | 814 |
|
|
2019
Q4 | $5M | Hold |
203,200
| – | – | 0.01% | 808 |
|
|
2019
Q3 | $2.1M | Hold |
203,200
| – | – | ﹤0.01% | 1012 |
|
|
2019
Q2 | $2.55M | Hold |
203,200
| – | – | ﹤0.01% | 957 |
|
|
2019
Q1 | $2.52M | Hold |
203,200
| – | – | ﹤0.01% | 938 |
|
|
2018
Q4 | $1.25M | Hold |
203,200
| – | – | ﹤0.01% | 1089 |
|
|
2018
Q3 | $2.15M | Sell |
203,200
-40,661
| -17% | -$464K | ﹤0.01% | 991 |
|
|
2018
Q2 | $3.3M | Buy |
243,861
+1,740
| +0.7% | +$27.1K | 0.01% | 864 |
|
|
2018
Q1 | $4.3M | Buy |
242,121
+159,636
| +194% | +$2.7M | 0.01% | 793 |
|
|
2017
Q4 | $1.03M | Buy |
82,485
+41,385
| +101% | +$602K | ﹤0.01% | 1235 |
|
|
2017
Q3 | $783K | Buy |
41,100
+21,100
| +106% | +$322K | ﹤0.01% | 1299 |
|
|
2017
Q2 | $302K | Hold |
20,000
| – | – | ﹤0.01% | 1372 |
|
|
2017
Q1 | $343K | Hold |
20,000
| – | – | ﹤0.01% | 1374 |
|
|
2016
Q4 | $242K | Hold |
20,000
| – | – | ﹤0.01% | 1410 |
|
|
2016
Q3 | $197K | Sell |
20,000
-20,000
| -50% | -$183K | ﹤0.01% | 1411 |
|
|
2016
Q2 | $410K | Buy |
40,000
+20,000
| +100% | +$223K | ﹤0.01% | 1393 |
|
|
2016
Q1 | $242K | Hold |
20,000
| – | – | ﹤0.01% | 1331 |
|
|
2015
Q4 | $320K | Hold |
20,000
| – | – | ﹤0.01% | 1264 |
|
|
2015
Q3 | $257K | Hold |
20,000
| – | – | ﹤0.01% | 1361 |
|
|
2015
Q2 | $480K | Hold |
20,000
| – | – | ﹤0.01% | 1302 |
|
|
2015
Q1 | $376K | Hold |
20,000
| – | – | ﹤0.01% | 1325 |
|
|
2014
Q4 | $377K | Hold |
20,000
| – | – | ﹤0.01% | 1316 |
|
|
2014
Q3 | $542K | Hold |
20,000
| – | – | ﹤0.01% | 1244 |
|
|
2014
Q2 | $622K | Hold |
20,000
| – | – | ﹤0.01% | 1272 |
|
|
2014
Q1 | $455K | Hold |
20,000
| – | – | ﹤0.01% | 1304 |
|
|
2013
Q4 | $416K | Hold |
20,000
| – | – | ﹤0.01% | 1292 |
|
|
2013
Q3 | $803K | Hold |
20,000
| – | – | ﹤0.01% | 1217 |
|
|
2013
Q2 | $563K | Buy |
+20,000
| New | +$514K | ﹤0.01% | 1263 |
|
Other funds holding EPZM
Macquarie Group's EPZM Position: Q3 2022 in Review
Macquarie Group sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 203,200 shares — an estimated $299K sold.
Macquarie Group first reported a position in EPZM in Q2 2013 and held it in 37 quarters. The position peaked at $5M in Q4 2019. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.
- Macquarie Group reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
- Macquarie Group sold 203,200 Epizyme, Inc shares in Q3 2022, an estimated $299K.
- Macquarie Group first reported a position in Epizyme, Inc in Q2 2013 and held it in 37 quarters.
- Macquarie Group's Epizyme, Inc position peaked at $5M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.
Based on Macquarie Group's 13F filing for Q3 2022, filed 14 Nov 2022.